93 related articles for article (PubMed ID: 10835669)
1. Gene therapy for human SCID: dreams become reality.
Buckley RH
Nat Med; 2000 Jun; 6(6):623-4. PubMed ID: 10835669
[No Abstract] [Full Text] [Related]
2. LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD
N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
[No Abstract] [Full Text] [Related]
3. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
Sponzilli I; Notarangelo LD
Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; Gross F; Yvon E; Nusbaum P; Selz F; Hue C; Certain S; Casanova JL; Bousso P; Deist FL; Fischer A
Science; 2000 Apr; 288(5466):669-72. PubMed ID: 10784449
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
[TBL] [Abstract][Full Text] [Related]
7. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
8. Medicine. Gene therapy--new challenges ahead.
Williams DA; Baum C
Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
[TBL] [Abstract][Full Text] [Related]
9. [Early recognition and successful treatment of an infant with severe combined immune deficiency].
Mosdósi B; Decsi T; Nagy K; Soltész G; Maródi L
Orv Hetil; 2002 Sep; 143(36):2081-3. PubMed ID: 12378899
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for severe combined immunodeficiency.
Cavazzana-Calvo M; Lagresle C; Hacein-Bey-Abina S; Fischer A
Annu Rev Med; 2005; 56():585-602. PubMed ID: 15660528
[TBL] [Abstract][Full Text] [Related]
11. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCormack MP; Wulffraat N; Leboulch P; Lim A; Osborne CS; Pawliuk R; Morillon E; Sorensen R; Forster A; Fraser P; Cohen JI; de Saint Basile G; Alexander I; Wintergerst U; Frebourg T; Aurias A; Stoppa-Lyonnet D; Romana S; Radford-Weiss I; Gross F; Valensi F; Delabesse E; Macintyre E; Sigaux F; Soulier J; Leiva LE; Wissler M; Prinz C; Rabbitts TH; Le Deist F; Fischer A; Cavazzana-Calvo M
Science; 2003 Oct; 302(5644):415-9. PubMed ID: 14564000
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.
Otsu M; Anderson SM; Bodine DM; Puck JM; O'Shea JJ; Candotti F
Mol Ther; 2000 Feb; 1(2):145-53. PubMed ID: 10933924
[TBL] [Abstract][Full Text] [Related]
13. Of mice and men: the tale of two therapies.
Hawley RG; Sobieski DA
Stem Cells; 2002; 20(4):275-8. PubMed ID: 12110695
[No Abstract] [Full Text] [Related]
14. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
Goebel WS; Nelson RP; Brahmi Z; Gowan DJ; Towell PJ; Robertson KA; Haut PR
Transplantation; 2006 Jun; 81(11):1596-9. PubMed ID: 16770250
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
[TBL] [Abstract][Full Text] [Related]
16. Delayed onset of (severe) combined immunodeficiency (S)CID (T-B+NK+): complete IL-7 receptor deficiency in a 22 months old girl.
Rossberg S; Schwarz K; Meisel C; Holzhauer S; Kühl J; Ebell W; Wahn V; von Bernuth H
Klin Padiatr; 2009; 221(6):339-43. PubMed ID: 19890784
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy: therapeutic gene causing lymphoma.
Woods NB; Bottero V; Schmidt M; von Kalle C; Verma IM
Nature; 2006 Apr; 440(7088):1123. PubMed ID: 16641981
[TBL] [Abstract][Full Text] [Related]
18. Role of natural killer T (NKT) cells lacking interleukin (IL)-4 producing abilities on the CC-chemokine ligand 2-associated herpes simplex virus type 1 infection in human severe combined immunodeficiency (SCID) mouse chimeras.
Fujita K; Sandford AP; Kobayashi M; Hanafusa T; Herndon DN; Suzuki F
Burns; 2005 Mar; 31(2):145-52. PubMed ID: 15683684
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoietic malignancies and gene therapy].
Ozawa K
Gan To Kagaku Ryoho; 2003 Apr; 30(4):478-82. PubMed ID: 12722677
[TBL] [Abstract][Full Text] [Related]
20. Thirty years of bone marrow transplantation for severe combined immunodeficiency.
Fischer A
N Engl J Med; 1999 Feb; 340(7):559-61. PubMed ID: 10021479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
